Accolade Inc
NASDAQ:ACCD
Accolade Inc
Gross Profit
Accolade Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Accolade Inc
NASDAQ:ACCD
|
Gross Profit
$164.2m
|
CAGR 3-Years
41%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Gross Profit
$3.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Gross Profit
$3.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
CVS Health Corp
NYSE:CVS
|
Gross Profit
$53.6B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
8%
|
|
Cigna Corp
NYSE:CI
|
Gross Profit
$25.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Gross Profit
$3.4B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
See Also
What is Accolade Inc's Gross Profit?
Gross Profit
164.2m
USD
Based on the financial report for Feb 28, 2023, Accolade Inc's Gross Profit amounts to 164.2m USD.
What is Accolade Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
48%
Over the last year, the Gross Profit growth was 16%. The average annual Gross Profit growth rates for Accolade Inc have been 41% over the past three years , 48% over the past five years .